Electronic sanitary database: a new potential tool to identify occult chronic liver disease in general population

被引:0
作者
Silvia Cagnin
Andrea Martini
Daniele Donato
Paolo Angeli
Patrizia Pontisso
机构
[1] Padova Teaching Hospital,Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine (DIMED)
[2] Padova Teaching Hospital,Medical Head Office
来源
Internal and Emergency Medicine | 2024年 / 19卷
关键词
Chronic liver disease; Cirrhosis; Epidemiology; Early diagnosis;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic liver disease (CLD) is a leading global cause of mortality, morbidity, and healthcare resource utilization. However, the burden of CLD is underestimated because the course of the disease is often asymptomatic until clinical decompensation and the development of life-threatening complications. In this study, we assessed the use of available blood tests from electronic medical records for identifying individuals with undiagnosed CLD in the general population. We analyzed a total of 202,529 blood tests obtained from 99,848 adults recorded in the Electronic Health Records of the Padova Teaching Hospital. Transaminases levels > 1.5 times the normal value indicated occult CLD, while platelet counts < 120,000/μL identified occult cirrhosis. We characterized patients using Italian Medical Exemptions (IME), excluding oncologic cases. Overt and occult cirrhosis prevalence was 1% and 4.18%, respectively, while overt and occult CLD affected 2.85% and 4.61% of the population. The epidemiology of patients with overt and occult cirrhosis was similar but significantly different from that of the controls. Among subjects aged 60–70 years, working disability was twofold higher in those with occult cirrhosis compared to those with overt cirrhosis. Occult CLD and cirrhosis had higher prevalence rates than diagnosed cases in the general population. Electronic medical record data may serve as a valuable tool for CLD identification, potentially reducing cirrhosis development and clinical decompensation. This, in turn, may lead to a decrease in the economic impact on the healthcare system.
引用
收藏
页码:641 / 647
页数:6
相关论文
共 124 条
  • [1] Younossi ZM(2019)Non-alcoholic fatty liver disease – a global public health perspective J Hepatol 70 531-544
  • [2] Marcellin P(2018)Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening Liver Int 38 2-6
  • [3] Kutala BK(2012)Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010 Lancet 380 2095-2128
  • [4] Lozano R(2019)Burden of liver diseases in the world J Hepatol 70 151-171
  • [5] Naghavi M(2020)Contemporary epidemiology of chronic liver disease and cirrhosis Clin Gastroenterol Hepatol 18 2650-2666
  • [6] Foreman K(2017)Hospitalizations due to cirrhosis: clinical aspects in a large cohort of Italian patients and cost analysis report Dig Dis 35 433-438
  • [7] Asrani SK(2018)Increasing health care burden of chronic liver disease compared with other chronic diseases, 2004–2013 Gastroenterology 155 719-729.e4
  • [8] Devarbhavi H(2022)The EASL–lancet liver commission: protecting the next generation of Europeans against liver disease complications and premature mortality Lancet 399 61-116
  • [9] Eaton J(2019)Global elimination of chronic hepatitis N Engl J Med 380 2041-2050
  • [10] Kamath PS(2017)Access to HCV treatments: hurdles not barriers Lancet Gastroenterol Hepatol 2 1-296